---
title: "ANDTY: Chief Financial Officer and Board Secretary Cha Xianbin resigns due to job changes"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/249100509.md"
description: "ANDTY announced that Chief Financial Officer and Board Secretary Cha Xianbin has resigned due to job changes, with the resignation taking effect upon delivery to the board of directors. The company's board of directors has agreed to appoint Wang Bin as the new Chief Financial Officer and Chen Long as the new Board Secretary, with terms lasting until the current board's term expires"
datetime: "2025-07-18T08:20:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/249100509.md)
  - [en](https://longbridge.com/en/news/249100509.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/249100509.md)
---

# ANDTY: Chief Financial Officer and Board Secretary Cha Xianbin resigns due to job changes

ANDTY announced on July 18th that the company's board of directors recently received a written resignation letter from Chief Financial Officer and Board Secretary Cha Xianbin. Cha Xianbin applied to resign from the positions of Chief Financial Officer and Board Secretary due to job changes, and the resignation will take effect upon delivery to the company's board of directors. After the resignation, he will no longer hold any position in the company. The company's board of directors agreed to appoint Wang Bin as the Chief Financial Officer, with a term starting from the date of approval by this board meeting until the end of the current board's term. The company's board of directors also agreed to appoint Chen Long as the Board Secretary, with a term starting from the date of approval by this board meeting until the end of the current board's term

### Related Stocks

- [002136.CN](https://longbridge.com/en/quote/002136.CN.md)

## Related News & Research

- [METALS-Copper dips as rate hike bets weigh on demand hopes](https://longbridge.com/en/news/294006535.md)
- [CSPC says China NMPA accepts sirolimus albumin-bound injection filing, grants priority review](https://longbridge.com/en/news/293936243.md)
- [Bénéteau flags availability of new press release on H1 2026 sales update](https://longbridge.com/en/news/293954581.md)
- [ORY: Clinical pipeline advances and new financing commitments drive growth and future outlook](https://longbridge.com/en/news/293965976.md)
- [Photon Design enables multi-junction VCSEL simulation for high-power applications](https://longbridge.com/en/news/293965957.md)